Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 2, 2026

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer
08:26

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer

Published on: March 24, 2013

Integrin imaging to evaluate treatment response.

Matthew Morrison1, Alan Cuthbertson

  • 11. GE Healthcare MDx Research, The Grove Centre, Amersham, HP7 9LL, U.K.

Theranostics
|May 7, 2011
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The load-velocity profiles and exercise-specific velocity zones for seven commonly used weightlifting exercises.

PloS one·2026
Same author

Wearing Lower-Body Compression Tights to Bed After Cycling Exercise Does Not Affect Subsequent Sleep in Healthy Male Adults.

Sensors (Basel, Switzerland)·2026
Same author

Annual Training Load and Jumping- and Sprinting-Characteristic Changes During a Periodized Training Plan in a Division I Male Championship Basketball Team.

International journal of sports physiology and performance·2025
Same author

The Applied Sport Science and Medicine of Powerlifting and Para Powerlifting: A Systematic Scoping Review with Recommendations for Future Research.

Sports medicine (Auckland, N.Z.)·2025
Same author

Quantifying the effect of afternoon moderate-intensity exercise on sleep quality and quantity in healthy adult males using polysomnography.

Journal of science and medicine in sport·2025
Same author

Overlap Diagnostic Odyssey and Full Mouth Rehabilitation of a Juvenile Patient With IFIH1-Related Disorder: A Case of Aicardi-Goutières and Singleton Merten Syndromes Overlap.

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry·2025
Same journal

Cardiomyocyte-derived USP20 mitigates myocardial ischemia/reperfusion injury through deubiquitinating GRP78.

Theranostics·2026
Same journal

Ion-Responsive Microneedles Delivering Subtype-Specific Mitochondrial Extracellular Vesicles from HEY1⁺ Cardiomyocytes for Cardiac Repair in Bama Minipigs with Myocardial Ischemia-Reperfusion Injury.

Theranostics·2026
Same journal

Mechano-immune interactions in musculoskeletal aging: Mechanisms and translational perspectives.

Theranostics·2026
Same journal

Peripheral blood immune profiling reveals key signatures in newly diagnosed NK/T cell lymphoma patients.

Theranostics·2026
Same journal

Sonogenetics for precision medicine: from molecular toolkit to clinical translation.

Theranostics·2026
Same journal

Programmable pH-responsive DNA inter-strand matching (PRISM) for precision molecular band-pass actuation.

Theranostics·2026
See all related articles

Novel radiolabeled peptides targeting RGD can non-invasively monitor tumor vascularity. These tracers assess anti-tumor therapies, particularly those targeting tumor blood vessels, enhancing understanding of treatment impact.

Area of Science:

  • Oncology
  • Radiochemistry
  • Molecular Imaging

Background:

  • Radiolabeled Arg-Gly-Asp (RGD) peptides are used to image the αvβ3 integrin receptor.
  • Limited research exists on using these radiotracers to monitor changes in tumor vascularity after anti-tumor therapy.

Purpose of the Study:

  • To evaluate novel radiolabeled RGD peptides for non-invasively monitoring tumor vascularity.
  • To assess the potential of these tracers in evaluating anti-tumor therapies, especially those targeting tumor vasculature.

Main Methods:

  • Development and characterization of novel radiolabeled RGD-containing peptides.
  • In vivo evaluation of tracer kinetics and tumor targeting in preclinical tumor models.
  • Assessment of tracer ability to monitor changes in tumor vascularity.
Keywords:
Cancer treatment responseRGD peptideRadiolabelingTumor vasculature.

More Related Videos

Imaging Integrin Tension and Cellular Force at Submicron Resolution with an Integrative Tension Sensor
07:20

Imaging Integrin Tension and Cellular Force at Submicron Resolution with an Integrative Tension Sensor

Published on: April 25, 2019

A Flow Cytometry-Based High-Throughput Technique for Screening Integrin-Inhibitory Drugs
04:15

A Flow Cytometry-Based High-Throughput Technique for Screening Integrin-Inhibitory Drugs

Published on: February 2, 2024

Related Experiment Videos

Last Updated: Jun 2, 2026

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer
08:26

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer

Published on: March 24, 2013

Imaging Integrin Tension and Cellular Force at Submicron Resolution with an Integrative Tension Sensor
07:20

Imaging Integrin Tension and Cellular Force at Submicron Resolution with an Integrative Tension Sensor

Published on: April 25, 2019

A Flow Cytometry-Based High-Throughput Technique for Screening Integrin-Inhibitory Drugs
04:15

A Flow Cytometry-Based High-Throughput Technique for Screening Integrin-Inhibitory Drugs

Published on: February 2, 2024

Main Results:

  • Several novel radiolabeled RGD peptides demonstrated favorable in vivo kinetics and tumor targeting.
  • These tracers successfully monitored tumor vascularity non-invasively across various preclinical models.
  • The tracers showed potential for assessing the impact of anti-tumor therapies on tumor blood vessels.

Conclusions:

  • Novel radiolabeled RGD peptides are effective tools for quantifying tumor vasculature non-invasively.
  • These agents can provide valuable information for assessing anti-tumor therapies targeting tumor blood vessels.
  • The use of these radiotracers can enhance the mechanistic understanding of novel therapeutic strategies' impact on tumors.